Brogden R N
Drugs. 1986;32 Suppl 4:27-45. doi: 10.2165/00003495-198600324-00004.
The largest group of non-narcotic analgesics are the arylalkanoic acid derivatives, comprising derivatives of arylacetic acid, propionic acid, heteraryl acetic acid and indole acetic acid. Common to all of these drugs is their inhibition of prostaglandin biosynthesis, which contributes to their analgesic and other pharmacological properties as well as to their principal side effect, gastrointestinal irritation. Although these drugs all cause some gastric microbleeding, they do so to a lesser extent than aspirin. The arylalkanoic acid derivatives, as well as the anthranilic acid and oxicam derivatives, are peripherally acting as evidenced by their lack of activity in classical tests of central analgesic activity. After oral administration of these drugs, their peak plasma concentrations are generally attained in 1 to 3 hours; absorption is not generally influenced by food. Volume of distribution is mostly low (less than 0.2 L/kg) and protein binding is high (usually 95 to 99%). Elimination is by glucuronide formation for several of the propionic acid derivatives and generally by biotransformation for derivatives of arylacetic acid, indole and indene acetic acid, and the oxicams. The elimination half-life of the arylalkanoic acid derivatives is in most instances about 2 to 5 hours, although notable exceptions include carprofen (approximately equal to 20 h), fenbufen (10 h), naproxen (12-15 h) and sulindac (16 h for the active metabolite). The elimination half-life of indomethacin varies considerably between and within individuals. Piroxicam has the longest half-life, averaging 45 hours. The pharmacokinetic properties of the anthranilic acid derivatives (fenamates, glafenine) generally resemble those of the arylacetic acids. Few clinically significant drug interactions are associated with concomitant administration of the arylalkanoic acids or piroxicam and other drugs. Since the arylalkanoic acids are highly bound to plasma proteins (mainly albumin) there is a theoretical potential for displacement reactions with drugs that are used at plasma concentrations high enough to exceed the binding capacity of their own primary binding sites. However, such reactions have rarely been reported. Although the concomitant administration of aspirin and several of the propionic acid derivatives results in a significant decrease in the plasma concentration of the latter, the clinical significance of such interactions is uncertain and probably minimal.(ABSTRACT TRUNCATED AT 250 WORDS)
最大的一类非麻醉性镇痛药是芳基链烷酸衍生物,包括芳基乙酸、丙酸、杂芳基乙酸和吲哚乙酸的衍生物。所有这些药物的共同之处在于它们抑制前列腺素的生物合成,这促成了它们的镇痛及其他药理特性,以及它们的主要副作用——胃肠道刺激。尽管这些药物都会引起一些胃微出血,但程度比阿司匹林轻。芳基链烷酸衍生物以及邻氨基苯甲酸和昔康衍生物是外周作用的,这一点从它们在经典中枢镇痛活性试验中缺乏活性可以得到证明。口服这些药物后,它们的血浆浓度通常在1至3小时内达到峰值;吸收一般不受食物影响。分布容积大多较低(小于0.2 L/kg),蛋白结合率较高(通常为95%至99%)。几种丙酸衍生物通过葡糖醛酸结合进行消除,而芳基乙酸、吲哚和茚乙酸衍生物以及昔康一般通过生物转化进行消除。芳基链烷酸衍生物的消除半衰期在大多数情况下约为2至5小时,不过明显的例外包括卡洛芬(约20小时)、芬布芬(10小时)、萘普生(12 - 15小时)和舒林酸(活性代谢物为16小时)。吲哚美辛的消除半衰期在个体之间和个体内部差异很大。吡罗昔康的半衰期最长,平均为45小时。邻氨基苯甲酸衍生物(芬那酯、格拉非宁)的药代动力学特性一般与芳基乙酸相似。同时使用芳基链烷酸或吡罗昔康与其他药物很少会产生具有临床意义的药物相互作用。由于芳基链烷酸与血浆蛋白(主要是白蛋白)高度结合,理论上存在与血浆浓度高到足以超过其自身主要结合位点结合能力的药物发生置换反应的可能性。然而,此类反应鲜有报道。尽管同时使用阿司匹林和几种丙酸衍生物会导致后者的血浆浓度显著降低,但这种相互作用的临床意义尚不确定,可能很小。(摘要截选至250词)